Monopar Therapeutics

MNPR · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.4B · 22 employees
175
SEC Filings
$109.96
Close 2026-09-10
22
Employees

Business Summary

Monopar Therapeutics (MNPR) is a clinical-stage biopharmaceutical company focused on developing novel therapeutics. Key pipeline assets include ALXN1840 (licensed from AstraZeneca) for Wilson disease, which holds Orphan Drug Designation in the U.S. and EU and FDA Fast Track designation, and MNPR-101, a radiopharmaceutical candidate. The company holds exclusive licenses to over 86 patent applications across 30+ countries for ALXN1840.

Latest Stock Quote

MNPR 2026-09-10 $109.96 O:$110.55 H:$112.56 L:$108.84 Vol:0.1M VWAP:$110.8159
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-16

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-272025-12-310001437749-26-010025EDGAR64K words
2025-03-312024-12-310001437749-25-009979EDGAR60K words
2024-03-282023-12-310001437749-24-009687EDGAR66K words
2023-03-232022-12-310001654954-23-003384EDGAR68K words
2022-03-242021-12-310001654954-22-003701EDGAR—
2021-03-252020-12-310001654954-21-003243EDGAR—
2020-03-272019-12-310001654954-20-003363EDGAR—
2019-02-262018-12-310001654954-19-002003EDGAR—
2018-03-262017-12-310001654954-18-003136EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-122026-06-300001437749-26-027164EDGAR27K words
2025-11-132025-09-300001437749-25-034617EDGAR25K words
2025-08-122025-06-300001437749-25-026042EDGAR23K words
2025-05-132025-03-310001437749-25-016263EDGAR21K words
2024-11-082024-09-300001437749-24-034048EDGAR23K words
2024-08-092024-06-300001437749-24-025651EDGAR21K words
2024-05-092024-03-310001437749-24-015454EDGAR19K words
2023-11-092023-09-300001437749-23-031066EDGAR24K words
2023-08-102023-06-300001437749-23-022874EDGAR23K words
2023-05-112023-03-310001654954-23-006119EDGAR19K words
2022-11-102022-09-300001654954-22-014939EDGAR22K words
2022-08-112022-06-300001654954-22-011015EDGAR21K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-120001437749-26-027165EDGAR1K words
2026-07-220001437749-26-024041EDGAR1K words
2026-03-270001437749-26-010030EDGAR1K words
2026-03-020001437749-26-006229EDGAR1K words
2025-11-130001437749-25-034618EDGAR1K words
2025-11-100001437749-25-033948EDGAR1K words
2025-09-240001437749-25-029819EDGAR21K words
2025-09-150001437749-25-029005EDGAR1K words
2025-08-120001437749-25-026043EDGAR1K words
2025-06-230001437749-25-020959EDGAR1K words

175 total filings indexed. 144 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

rare/orphan-diseases radiopharmaceuticals oncology hatch-waxman-amendments-(drug-price-competition-and-patent-term-restoration-act-of-1984) uspto-patent-prosecution-standards fda-orphan-drug-designation fda-fast-track-designation

Company Identity

CIK0001645469
TickerMNPR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.monopartx.com
Listed2019-12-19

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 39871fcba22e92e556c92d232e9dfa9bf4822df653fa6b1745c67c18ffa9276a
parent: 74d0f6e7292f50fa59cfb7da30dcc84eded831dae66851755823a87a271696ab
content hash: f24e7765150dbc7c9781d64723dda6a57ea82eac01b561ea690a896cd87b2d6b
signed: 2026-09-30T12:02:10.594Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up MNPR using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on MNPR, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/MNPR (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.